{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:46:20Z","timestamp":1793745980498,"version":"4.6.1"},"reference-count":168,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jhep.2021.01.014","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:40:49Z","timestamp":1611142849000},"page":"1200-1211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["The changing context of hepatitis D"],"prefix":"10.1016","volume":"74","author":[{"given":"Mario","family":"Rizzetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.01.014_bib1","first-page":"157","article-title":"Advances in hepatitis D virus biology and disease","volume":"vol. XII","author":"Smedile","year":"1994"},{"key":"10.1016\/j.jhep.2021.01.014_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.014_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2021.01.014_bib5","first-page":"S37","article-title":"Comparison of Murex anti-Delta (Total) and ETI-AB-DELTAK-2 ELISAs for the detection of total antibodies against hepatitis D virus","volume":"46","author":"De Baere","year":"2009","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12985-020-01355-5","article-title":"Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan","volume":"17","author":"Lin","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2021.01.014_bib7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jmv.23336","article-title":"Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania","volume":"84","author":"Mansour","year":"2012","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.28772","article-title":"First international external quality assessment for hepatitis delta virus RNA quantification in plasma","volume":"64","author":"Le Gal","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib10","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1128\/JCM.43.5.2363-2369.2005","article-title":"Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients","volume":"43","author":"Le Gal","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2021.01.014_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.virusres.2018.03.013","article-title":"Hepatitis D diagnostics: utilization and testing in the United States","volume":"250","author":"Safaie","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.jhep.2021.01.014_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhep.2016.10.007","article-title":"Hepatitis delta-associated mortality in HIV\/HBV-coinfected patients","volume":"66","author":"B\u00e9guelin","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib13","series-title":"Clinical Epidemiology of Chronic Liver Diseases","first-page":"135","article-title":"Hepatitis D virus","author":"Rizzetto","year":"2019"},{"key":"10.1016\/j.jhep.2021.01.014_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.dld.2018.09.008","article-title":"The present profile of chronic hepatitis B virus infection highlights future challenges: an analysis of the Multicenter Italian MASTER-B cohort","volume":"51","author":"Brancaccio","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0000000000000795","article-title":"Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain","volume":"29","author":"Ordieres","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s15010-016-0956-1","article-title":"Hepatitis delta infection in Italian patients: towards the end of the story?","volume":"45","author":"Stroffolini","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.jhep.2021.01.014_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15403\/jgld.2014.1121.244.dtv","article-title":"Hepatitis Delta virus infection in Romania: prevalence and risk factors","volume":"24","author":"Gheorghe","year":"2015","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib18","first-page":"37","article-title":"Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies","volume":"57","author":"Turcanu","year":"2019","journal-title":"Rom J Intern Med"},{"issue":"suppl","key":"10.1016\/j.jhep.2021.01.014_bib19","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(12)60173-1","article-title":"Hepatitis Delta-Still of major concern in Russia due to immigration and in intravenous drug-usage; view from large single center cohort","volume":"56","author":"Yesmembetov","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.dld.2018.05.006","article-title":"Liver-related mortality in hepatitis delta patients: Russian single center experience","volume":"50","author":"Abdurakhmanov","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib21","doi-asserted-by":"crossref","first-page":"a021576","DOI":"10.1101\/cshperspect.a021576","article-title":"Hepatitis D virus: introduction and epidemiology","volume":"5","author":"Rizzetto","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhep.2021.01.014_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3851\/IMP3161","article-title":"Decline and changing profile of hepatitis delta among injection drug users in Spain","volume":"23","author":"Aguilera","year":"2018","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2021.01.014_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jmv.23370","article-title":"Hepatitis C virus infection among drug addicts in Italy","volume":"84","author":"Stroffolini","year":"2012","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib24","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/hep.27742","article-title":"Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program","volume":"61","author":"Lin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0032-1316467","article-title":"Hepatitis delta and HIV infection","volume":"32","author":"Calle Serrano","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s11904-020-00508-z","article-title":"Epidemiology, natural history, and treatment of hepatitis delta virus infection in HIV\/hepatitis B virus coinfection","author":"Ferrante","year":"2020","journal-title":"3rd Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jhep.2021.01.014_bib27","series-title":"Oxford Textbook of Clinical Hepatology","first-page":"899","article-title":"Hepatitis D","author":"Rizzetto","year":"1999"},{"key":"10.1016\/j.jhep.2021.01.014_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijid.2020.09.004","article-title":"Prevalence and factors associated with hepatitis B and D virus infections among migrant sex workers in Chiangmai, Thailand: a cross-sectional study in 2019","volume":"100","author":"Hongjaisee","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0032-1323626","article-title":"Epidemiology of hepatitis D","volume":"32","author":"Rizzetto","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13310","article-title":"Migratory flow and hepatitis Delta infection in Italy: a new challenge at the beginning of the third millennium","author":"Stroffolini","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"Wedemeyer","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.07.005","article-title":"Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study","volume":"59","author":"Manesis","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2018.07.005","article-title":"Epidemiology and clinical outcomes of hepatitis delta (D) virus infection in Queensland, Australia","volume":"74","author":"Coghill","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.rce.2016.02.005","article-title":"Viral hepatitis and immigration: a challenge for the healthcare system","volume":"216","author":"Cuenca-G\u00f3mez","year":"2016","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.jhep.2021.01.014_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hep.28279","article-title":"Prevalence of hepatitis delta infection in the United States: national health and nutrition examination survey, 1999-2012","volume":"64","author":"Njei","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/cid\/ciz001","article-title":"Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016","volume":"69","author":"Patel","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2015.04.025","article-title":"Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes","volume":"63","author":"Kushner","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib38","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jgh.12217","article-title":"Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California","volume":"28","author":"Gish","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib39","article-title":"High prevalence of chronic viral hepatitis and liver fibrosis among Mongols in Southern California","author":"Fong","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2021.01.014_bib40","article-title":"Risk factors for Delta hepatitis in a North American cohort: who should be screened?","author":"Da","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21149\/11128","article-title":"Reduction of HBV and HDV infection in two indigenous peoples of Peruvian Amazon after the vaccination against hepatitis B","volume":"62","author":"Cabezas","year":"2020","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.jhep.2021.01.014_bib42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3748\/wjg.v16.i5.554","article-title":"Hepatitis D: scenario in the Asia-Pacific region","volume":"16","author":"Abbas","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib44","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.8210","article-title":"Prevalence of hepatitis D in the eastern Mediterranean region: systematic review and meta-analysis","volume":"13","author":"Amini","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jhep.2021.01.014_bib45","first-page":"606","article-title":"Epidemiology of viral hepatitis in the Maghreb","volume":"96","author":"Lahlali","year":"2018","journal-title":"Tunis Med"},{"key":"10.1016\/j.jhep.2021.01.014_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jmv.25301","article-title":"Hepatitis B virus and hepatitis delta virus subtypes circulating in Algeria and seroprevalence of HDV infection","volume":"91","author":"Gourari","year":"2019","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2015.10.002","article-title":"Molecular epidemiology of hepatitis B and delta virus strains that spread in the mediterranean north East coast of Tunisia","volume":"72","author":"Yacoubi","year":"2015","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.11604\/pamj.2020.35.120.20055","article-title":"The epidemiological characterization and geographic distribution of hepatitis D virus infection in Libya","volume":"35","author":"Daw","year":"2020","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jhep.2021.01.014_bib49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajg.2017.11.003","article-title":"Prevalence and risk factors of hepatitis D virus infection in patients with chronic hepatitis B infection attending the three main tertiary hospitals in Libya","volume":"18","author":"Elzouki","year":"2017","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib50","first-page":"23","article-title":"Seroprevalence of HDV infection in HBsAg positive population in Ismailia, Egypt. Egypt","volume":"20","author":"Gomaa","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.01.014_bib51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jmv.24412","article-title":"Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D","volume":"88","author":"Fouad","year":"2016","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/sjg.SJG_515_16","article-title":"Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: a single-center study","volume":"23","author":"Jamjoom","year":"2017","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12879-018-3008-x","article-title":"Characterization of hepatitis B and delta coinfection in Israel","volume":"18","author":"Shirazi","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.puhe.2020.06.024","article-title":"The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey","volume":"185","author":"Kasradze","year":"2020","journal-title":"Public Health"},{"key":"10.1016\/j.jhep.2021.01.014_bib55","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.32354","article-title":"Hepatitis D virus infection among hepatitis B surface antigen carriers and in isolated anti-HBc antibodies profile in central Tunisia","volume":"16","author":"Mhalla","year":"2016","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jhep.2021.01.014_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jiph.2018.12.001","article-title":"Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: prevalence and clinical features","volume":"12","author":"Makhlouf","year":"2019","journal-title":"J\u00a0Infect Publ Health"},{"key":"10.1016\/j.jhep.2021.01.014_bib57","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","article-title":"Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study","volume":"21","author":"Tozun","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2021.01.014_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2893.2010.01329.x","article-title":"Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider","volume":"18","author":"Bahcecioglu","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5114\/aoms.2015.52030","article-title":"High prevalence of chronic hepatitis D virus infection in Eastern Turkey: urbanization of the disease","volume":"12","author":"Dulger","year":"2016","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jhep.2021.01.014_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15171\/hpp.2020.07","article-title":"Prevalence of hepatitis D virus among HBsAg-positive individuals, 2015-2016: Azar cohort study","volume":"10","author":"Pouri","year":"2020","journal-title":"Health Promot Perspect"},{"key":"10.1016\/j.jhep.2021.01.014_bib61","first-page":"145","article-title":"Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections","volume":"11","author":"Sayad","year":"2018","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.jhep.2021.01.014_bib62","first-page":"260","article-title":"Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan","volume":"51","author":"Bakhshipour","year":"2013","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.jhep.2021.01.014_bib63","first-page":"1906","article-title":"Histological and serological epidemiology of hepatitis Delta virus coinfection among patients with chronic active hepatitis B virus in Razavi Khorasan Province, Northeastern Iran","volume":"47","author":"Sharifan","year":"2018","journal-title":"Iran J Publ Health"},{"key":"10.1016\/j.jhep.2021.01.014_bib64","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jmv.25196","article-title":"Hepatitis D infection in Brazil: prevalence and geographical distribution of anti-Delta antibody","volume":"90","author":"Lago","year":"2018","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib65","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0289-2018","article-title":"Hepatitis Delta prevalence in South America: a systematic review and meta-analysis","volume":"52","author":"Scarponi","year":"2019","journal-title":"Rev Soc Bras Med Trop"},{"issue":"Suppl 3","key":"10.1016\/j.jhep.2021.01.014_bib66","first-page":"24","article-title":"The status of hepatitis B control in the African region","volume":"27","author":"Breakwell","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jhep.2021.01.014_bib67","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1016\/S2214-109X(17)30298-X","article-title":"Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis","volume":"5","author":"Stockdale","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhep.2021.01.014_bib68","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/gutjnl-2019-320027","article-title":"The epidemiology of hepatitis delta virus infection in Cameroon","volume":"69","author":"Besombes","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.014_bib69","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1038\/s41598-018-30078-5","article-title":"High prevalence of hepatitis delta virus in Cameroon","volume":"8","author":"Butler","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2021.01.014_bib70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jvh.12991","article-title":"High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon","volume":"26","author":"Groc","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib71","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12879-016-1992-2","article-title":"A\u00a0prominent role of Hepatitis D Virus in liver cancers documented in Central Africa","volume":"16","author":"Amougou","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006377","article-title":"Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults","volume":"12","author":"Komas","year":"2018","journal-title":"Plos Negl Trop Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib73","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1128\/JCM.01847-16","article-title":"High prevalence and diversity of hepatitis viruses in suspected cases of Yellow Fever in the Democratic Republic of Congo","volume":"55","author":"Makiala-Mandanda","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2021.01.014_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5005\/jp-journals-10018-1168","article-title":"Viral hepatitis in Mongolia: past, present, and future","volume":"6","author":"Tsatsralt-Od","year":"2016","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib75","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.28957","article-title":"A\u00a0novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected Mongolians","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib76","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/liv.14243","article-title":"The medical impact of hepatitis D virus infection in Uzbekistan","volume":"39","author":"Khodjaeva","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib77","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jmv.21057","article-title":"Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan","volume":"80","author":"Khan","year":"2008","journal-title":"J\u00a0Med Virol"},{"issue":"suppl","key":"10.1016\/j.jhep.2021.01.014_bib78","first-page":"S499","article-title":"The first results of genotyping of virus hepatitis D and virus hepatitis B in Kazakhstan","volume":"68","author":"Ilyassova","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib79","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-019-04285-y","article-title":"Epidemiology of blood-borne viral infections in Afghanistan","volume":"164","author":"Husseini","year":"2019","journal-title":"Arch Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078094","article-title":"High prevalence and significance of hepatitis D virus infection among treatment-na\u00efve HBsAg-positive patients in Northern Vietnam","volume":"8","author":"Sy","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.01.014_bib81","first-page":"56","article-title":"Assessment of external risk factors of hepatocellular cancer development and markers of genetic predisposition to its development in the ethnic group of Yakut men","volume":"92","author":"Yushchuk","year":"2020","journal-title":"Ter Arkh"},{"key":"10.1016\/j.jhep.2021.01.014_bib82","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1440-1746.2005.03857.x","article-title":"Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan","volume":"20","author":"Mumtaz","year":"2005","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/1743-422X-8-420","article-title":"True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach","volume":"8","author":"Khan","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2021.01.014_bib84","first-page":"624","article-title":"HDV seroprevalence in HBsAg positive patients","volume":"24","author":"Abbasi","year":"2014","journal-title":"Coll Phys Surg Pak"},{"key":"10.1016\/j.jhep.2021.01.014_bib85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2012.05.011","article-title":"Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania","volume":"55","author":"Mansour","year":"2012","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib86","first-page":"448","article-title":"Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study","volume":"67","author":"Lunel-Fabiani","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhep.2021.01.014_bib87","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jmv.20544","article-title":"Molecular epidemiology of hepatitis B virus in Dakar","volume":"78","author":"Vray","year":"2006","journal-title":"S\u00e9n\u00e9gal J Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib88","article-title":"Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study","volume":"9","author":"Langhoff H\u00f8nge","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.01.014_bib89","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/23744235.2019.1620963","article-title":"Low hepatitis D seroprevalence in blood donors of Bamako, Mali","volume":"51","author":"Marino","year":"2019","journal-title":"Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib90","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2214-109X(17)30463-1","article-title":"Epidemiological data for hepatitis D in Africa","volume":"6","author":"Tuaillon","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhep.2021.01.014_bib91","first-page":"32","article-title":"Prevalence of hepatitis D infection in patients with hepatitis B virus-related liver diseases in Accra, Ghana","volume":"33","author":"Asmah","year":"2014","journal-title":"West Afr J Med"},{"key":"10.1016\/j.jhep.2021.01.014_bib92","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jmv.23951","article-title":"Prevalence of HBV, HDV, HCV, and HIV infection during pregnancy in northern Benin","volume":"86","author":"De Paschale","year":"2014","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12985-016-0514-6","article-title":"Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria","volume":"13","author":"Opaleye","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2021.01.014_bib94","first-page":"439","article-title":"Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases","volume":"12","author":"Nwokediuko","year":"2009","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.jhep.2021.01.014_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134037","article-title":"Prevalence and characteristics of hepatitis B virus (HBV) coinfection among HIV-positive women in South Africa and Botswana","volume":"10","author":"Matthews","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.01.014_bib96","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1016\/j.vaccine.2013.08.028","article-title":"The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa","volume":"31","author":"Andersson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jhep.2021.01.014_bib97","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jmv.21010","article-title":"Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique","volume":"79","author":"Cunha","year":"2007","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib98","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3748\/wjg.v24.i34.3927","article-title":"Epidemiology of viral hepatitis in Somalia: systematic review and meta-analysis study","volume":"24","author":"Hassan-Kadle","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib99","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12985-017-0844-z","article-title":"Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia","volume":"14","author":"Belyhun","year":"2017","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2021.01.014_bib100","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1111\/liv.13607","article-title":"Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia","volume":"38","author":"Aberra","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib101","doi-asserted-by":"crossref","first-page":"104527","DOI":"10.1016\/j.jcv.2020.104527","article-title":"Hepatitis B and D in the pacific islands of Kiribati","volume":"129","author":"Jackson","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib102","first-page":"203","article-title":"Viral hepatitis in India","volume":"19","author":"Acharya","year":"2006","journal-title":"Natl Med J India"},{"key":"10.1016\/j.jhep.2021.01.014_bib103","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12664-015-0555-6","article-title":"Prevalence of hepatitis D virus infection among hepatitis B virus-infected individuals in India","volume":"34","author":"Jat","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2325957413488166","article-title":"High prevalence of hepatitis Delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region","volume":"13","author":"Saravanan","year":"2014","journal-title":"J\u00a0Int Assoc Provid AIDS Care"},{"key":"10.1016\/j.jhep.2021.01.014_bib105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1440-1746.1997.tb00364.x","article-title":"Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors","volume":"12","author":"Huo","year":"1997","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib106","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jmv.24417","article-title":"Clinical analysis of patients suffering from chronic hepatitis B superinfected with other hepadnaviruses","volume":"88","author":"Fu","year":"2016","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115888","article-title":"Epidemiological, clinical and histological characteristics of HBV\/HDV co-infection: a retrospective cross-sectional study in Guangdong, China","volume":"9","author":"Liao","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.01.014_bib108","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12879-020-05275-1","article-title":"Molecular epidemiology and clinical characteristics of hepatitis delta virus (HDV) infected patients with elevated transaminases in Shanghai, China","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib109","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/infdis\/jiz038","article-title":"Territory-wide prevalence study on blood-borne and enteric viral hepatitis in Hong Kong","volume":"219","author":"Liu","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib110","first-page":"17","article-title":"Prevalence of anti-delta antibodies in pregnant women in Bandung, Indonesia","volume":"40","author":"Vranckx","year":"1988","journal-title":"Trop Geogr Med"},{"key":"10.1016\/j.jhep.2021.01.014_bib111","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1348-0421.2003.tb03457.x","article-title":"Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia","volume":"47","author":"Lusida","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jhep.2021.01.014_bib112","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B","volume":"46","author":"Fattovich","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.01.014_bib113","article-title":"The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal","author":"Rizzetto","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib114","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/oxfordjournals.aje.a113533","article-title":"Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy","volume":"117","author":"Smedile","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2021.01.014_bib115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(85)92497-3","article-title":"Clinical significance of antibody to the hepatitis Delta Virus in asymptomatic HBsAg carriers","volume":"2","author":"Aric\u00f2","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2021.01.014_bib116","first-page":"95","article-title":"Seroprevalence of serum HBsAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey","volume":"165","author":"Mese","year":"2014","journal-title":"Clin Ter"},{"key":"10.1016\/j.jhep.2021.01.014_bib117","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2013.11.016","article-title":"Increasing prevalence of HDV\/HBV infection over 15 years in France","volume":"59","author":"Servant-Delmas","year":"2014","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhep.2021.01.014_bib118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/liv.13205","article-title":"Non-invasive fibrosis score for hepatitis delta","volume":"37","author":"Lutterkort","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib119","doi-asserted-by":"crossref","first-page":"104691","DOI":"10.1016\/j.antiviral.2019.104691","article-title":"The Delta-4 fibrosis score (D4FS): a novel fibrosis score in chronic hepatitis D","volume":"174","author":"Da","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2021.01.014_bib120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/liv.13604","article-title":"Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4254\/wjh.v12.i6.277","article-title":"Changing delta hepatitis patient profile: a single center experience in Valencia region, Spain","volume":"12","author":"Hern\u00e0ndez-\u00c8vole","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib122","unstructured":"Caviglia GP, Martini S, Ciancio A, Niro GA, Olivero A, Fontana R, et al. The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease. J Adv Res, in press."},{"key":"10.1016\/j.jhep.2021.01.014_bib123","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"Annual report of the European liver transplant Registry (ELTR) - 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib124","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0033-1345715","article-title":"Chronic hepatitis B: a treatment update","volume":"33","author":"Wong","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta","author":"Roulot","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31214","article-title":"Long-term study of hepatitis D infection at secondary care centers: the impact of viremia on liver-related outcomes","author":"Kamal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib127","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0b013e32834babb3","article-title":"Hepatitis delta in HIV-infected individuals in Europe","volume":"25","author":"Soriano","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2021.01.014_bib128","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/ciu127","article-title":"Increasing incidence of recent hepatitis D virus infection in HIV-infected patients in an area hyperendemic for hepatitis B virus infection","volume":"58","author":"Hung","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib129","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/cid\/ciu167","article-title":"Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients","volume":"58","author":"Fern\u00e1ndez-Montero","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1743-422X-8-368","article-title":"An overview of triple infection with hepatitis B, C and D viruses","volume":"8","author":"Riaz","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2021.01.014_bib131","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/jhep.2000.19288","article-title":"Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis","volume":"32","author":"Sagnelli","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib132","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1572-0241.1998.00354.x","article-title":"Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers","volume":"93","author":"Liaw","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.014_bib133","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2893.2009.01144.x","article-title":"Virological and clinical characteristics of delta hepatitis in Central Europe","volume":"16","author":"Heidrich","year":"2009","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib134","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1478-3231.2012.02831.x","article-title":"HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome","volume":"32","author":"Heidrich","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2010.06.008","article-title":"Outcome of chronic delta hepatitis in Italy: a long-term cohort study","volume":"53","author":"Niro","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib136","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2010.01324.x","article-title":"Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study","volume":"18","author":"Buti","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib137","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.014_bib138","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"73","author":"Alfaiate","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib139","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13366","article-title":"Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta","author":"Wranke","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib141","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/155.1.72","article-title":"Titration of the infectivity of hepatitis D virus in chimpanzees","volume":"155","author":"Ponzetto","year":"1987","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib142","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2036.2012.04993.x","article-title":"Meta-analysis: antiviral treatment for hepatitis D","volume":"35","author":"Triantos","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.01.014_bib143","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/apt.13734","article-title":"HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response","volume":"44","author":"Niro","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.01.014_bib144","article-title":"Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFN\u03b1-based antiviral treatment of hepatitis delta: results from the HIDIT-II study","author":"Bremer","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.014_bib145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0037-1621711","article-title":"Targeting Hepatitis D","volume":"38","author":"Rizzetto","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib146","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF02253420","article-title":"Inhibition of hepatitis Delta virus genomic ribozyme self-cleavage by aminoglycosides","volume":"4","author":"Chia","year":"1997","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.jhep.2021.01.014_bib147","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1261\/rna.2300406","article-title":"Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries","volume":"12","author":"Yen","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.jhep.2021.01.014_bib148","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.01.014_bib149","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib150","first-page":"133","article-title":"Prenylation of HDAg and antiviral drug development","volume":"307","author":"Glenn","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2021.01.014_bib151","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2016.07.004","article-title":"Nucleic acid polymers: broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection","volume":"133","author":"Vaillant","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2021.01.014_bib152","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib153","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1473-3099(15)00074-2","article-title":"Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial","volume":"15","author":"Koh","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2021.01.014_bib154","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2468-1253(17)30288-1","article-title":"Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial","volume":"2","author":"Bazinet","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"suppl","key":"10.1016\/j.jhep.2021.01.014_bib155","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0168-8278(18)30224-1","article-title":"Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with tenofovir in patients with chronic HBV\/HDV co-infection","volume":"68","author":"Wedemeyer","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"suppl","key":"10.1016\/j.jhep.2021.01.014_bib156","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S0618-8278(19)30141-0","article-title":"Interim results of a multicentre, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of Myrcludex B in combination with peg-interferon alpha 2a in patients with chronic HBV\/HDV co-infection","volume":"70","author":"Wedemeyer","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib157","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0168-8278(20)30651-6","article-title":"48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV\/HDV coinfection","volume":"73","author":"Wedemeyer","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib158","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s40265-020-01400-1","article-title":"Bulevirtide: first approval","volume":"80","author":"Kang","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2021.01.014_bib159","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.29658","article-title":"Optimizing lonafarnib treatment for the management of chronic delta hepatitis: the LOWR HDV-1 study","volume":"67","author":"Yurdaydin","year":"2018","journal-title":"Hepatology"},{"issue":"suppl 2","key":"10.1016\/j.jhep.2021.01.014_bib160","first-page":"10","article-title":"A\u00a0phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis - analysis from the LOWR HDV-2 study using the Robogene real-time qPCR HDV RNA assay","volume":"25","author":"Yurdaydin","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2021.01.014_bib161","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0168-8278(17)30464-6","article-title":"A\u00a0phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis \u2013 end of study results results from from the LOWR HDV-3 study","volume":"66","author":"Koh","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib162","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0168-8278(17)30310-0","article-title":"A\u00a0phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the lonafarnib with ritonavir in HDV-4 (LOWR HDV-4)","volume":"66","author":"Wedemeyer","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"suppl","key":"10.1016\/j.jhep.2021.01.014_bib163","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S0618-8278(19)30058-1","article-title":"End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection","volume":"70","author":"Etzion","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib164","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"HIDIT Study Group. Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.01.014_bib165","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jhep.2018.12.022","article-title":"Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy","volume":"70","author":"Yurdaydin","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.014_bib166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.31008","article-title":"RNA interference therapy with ARC-520 results in prolonged hepatitis B surface antigen response in patients with chronic hepatitis B infection","volume":"72","author":"Yuen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib167","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis and treatment and of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.01.014_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:52:01Z","timestamp":1726051921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":168,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0168827821000234"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.01.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The changing context of hepatitis D","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}